Spironolactone did not lower cardiovascular risks in patients undergoing maintenance dialysis in the phase 3 ACHIEVE trial. Spironolactone does not lower risk for cardiovascular (CV) mortality and ...
Adding spironolactone to a regimen that includes maximal ACE inhibition improves renoprotection in patients with diabetic nephropathy, data suggest. The finding is based on a placebo-controlled, ...
Hair loss is a common concern for many women, affecting both self-esteem and confidence. Among the various treatments available, spironolactone and finasteride are two medications frequently discussed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results